Our mission at Alcyomics is to provide novel solutions for the assessment of safety and efficacy of pharmaceuticals, cosmetics and chemicals. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling more cost-effective commercialisation of products and or drugs offering a reliable alternative to animal testing for safety and potency assessment of novel compounds. We use our patented technology, Skimune®, a non-artificial human skin explant test to accurately predict adverse immune reactions. For example we can assist in clinical trial development by evaluation of dose response. We work to Good Laboratory Practice and to ISO9001 standards and our safety and efficacy reports have been submitted to regulatory authorities to support, for example clinical trial applications.